KantarHealth Expands Its China Leadership Team

Email this to a friend

25.09.2009 United States

Naming Hettie Han Director of Healthcare Research

    NEW YORK, September 25, 2009 - KantarHealth continues to expand its leadership team in China, naming Hettie Han Director of Healthcare Research in its Beijing office. Ms. Han will be responsible for providing research programs and consulting guidance to help pharmaceutical and biotech clients optimize their business results in the Chinese market, anticipated to be the largest in the world by 2050. Formed by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment, KantarHealth is the world’s leading healthcarefocused global consultancy, specializing in portfolio optimization, market access, safety and outcomes, and brand and customer insights.

    "Hettie is a powerful addition to our senior team, with more than a decade of pharmaceutical research experience, including deep expertise in the critical oncology category," says Scott Davies, General Manager of KantarHealth China. "Having spent her career working in pharmaceutical companies, she has firsthand insight into our customers’ needs and challenges so can truly partner with them to drive their growth in the Chinese market."

    "I am excited by KantarHealth’s commitment to supporting its clients’ success-locally and around the world," says Ms. Han. "Its focus on providing evidence-based decision support, its broad global footprint, its worldwide communities of business and therapeutic experts and its unparalleled range of competencies ensure I can always bring my customers the best solutions and best support team to maximize their performance."

    Ms. Han Brings More Than 10 Years of Healthcare Experience to Her New Role

    Ms. Han comes to KantarHealth from Bristol-Myers Squibb, where she served as Global Oncology Marketing Research Manager, focused on emerging markets. With more than 10 years of healthcare research experience, she also has held analyst roles at several US and Chinabased pharmaceutical companies, including Penwest, Purdue, and Kunming Pharmaceuticals.

    A Chinese national, Ms Han graduated from Yunnan University. She also earned her MBA at the University of Connecticut.

    About KantarHealth...

    KantarHealth is the world’s leading healthcare-focused global consultancy, specializing in portfolio optimization, market access, safety and outcomes, and brand and customer insights Formed by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment, it is the next-generation decision support partner to the pharmaceutical and biotech industries, delivering evidence-based guidance to support clients’ global and local success.

    With 40+ offices throughout the Americas, Europe, Asia-Pacific, the Middle East and Africa, KantarHealth provides the broadest global footprint, coupled with the strongest local knowledge to help drive clients’ maximum performance in every geography. Market-leading solutions ensure optimal decisions and actions across the brand life cycle, from assessing opportunities and sizing markets...to developing products and building access strategies...to positioning brands and creating messaging...to managing stakeholder relationships and monitoring treatment outcomes.

    Contact Information...

    For more information on KantarHealth, please contact Ilene Siegalovsky, Senior Vice President, Marketing and Communications, at Ilene.Siegalovsky@kantarhealth.com or 201-836-0040, ext. 225.

    © 1998-2012 TNS, a Kantar Group Company. All rights reserved.
    TNS UK Ltd. Registered in England and Wales under number: 03073845 Registered Office: TNS House, Westgate, London W5 1UA